Breaking News

Today
Show Full Stories

X

To view all stories in expanded form, please subscribe.
Send Info
Hot Stocks
Legend Biotech reports Janssen summited NDA to Japan's MHLW for cilta-cel » 09:38
12/07/21
12/07
09:38
12/07/21
09:38
LEGN

Legend Biotech

$44.95 /

+0.7 (+1.58%)

, JNJ

Johnson & Johnson

$162.91 /

+3.555 (+2.23%)

Legend Biotech (LEGN)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
LEGN Legend Biotech
$44.95 /

+0.7 (+1.58%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

LEGN Legend Biotech
$44.95 /

+0.7 (+1.58%)

10/08/21 BTIG
Legend Biotech price target raised to $65 from $55 at BTIG
06/02/21 Jefferies
Legend Biotech cilta-cel PFS rate 'largely exceeds' expectation, says Jefferies
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
05/17/21 BTIG
Legend Biotech initiated with a Buy at BTIG
JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
LEGN Legend Biotech
$44.95 /

+0.7 (+1.58%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

LEGN Legend Biotech
$44.95 /

+0.7 (+1.58%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

Conference/Events
Goldman Sachs to hold a conference » 09:27
12/07/21
12/07
09:27
12/07/21
09:27
SYF

Synchrony

$46.34 /

+1.075 (+2.37%)

, WFC

Wells Fargo

$48.81 /

+1.07 (+2.24%)

, HIG

Hartford Financial

$67.65 /

+1.05 (+1.58%)

, CFG

Citizens Financial

$47.55 /

+1.21 (+2.61%)

, COIN

Coinbase

$263.27 /

-2.11 (-0.80%)

, CBOE

Cboe Global Markets

$131.07 /

+2.21 (+1.72%)

, VOYA

Voya Financial

$63.08 /

+0.78 (+1.25%)

, AB

AllianceBernstein

$52.30 /

+1.455 (+2.86%)

, ALLY

Ally Financial

$47.04 /

+0.72 (+1.55%)

, IBKR

Interactive Brokers

$75.55 /

+0.585 (+0.78%)

, PNC

PNC Financial

$199.91 /

+2.18 (+1.10%)

, PWP

Perella Weinberg Partners

$12.08 /

+0.24 (+2.03%)

, DFS

Discover

$111.93 /

+3.28 (+3.02%)

, COF

Capital One

$145.86 /

+3.96 (+2.79%)

, EFX

Equifax

$282.12 /

-0.34 (-0.12%)

, IVZ

Invesco

$22.76 /

+0.325 (+1.45%)

, SNV

Synovus

$46.95 /

+1.69 (+3.73%)

, ZION

Zions Bancorp

$63.78 /

+1.81 (+2.92%)

, BLK

BlackRock

$896.18 /

+0.56 (+0.06%)

, SPGI

S&P Global

$456.31 /

+0.04 (+0.01%)

, ICE

IntercontinentalExchange

$130.82 /

+0.65 (+0.50%)

, ADS

Alliance Data

$72.30 /

+1.545 (+2.18%)

, OWL

Blue Owl Capital

$15.40 /

+0.33 (+2.19%)

2021 US Financial…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
SYF Synchrony
$46.34 /

+1.075 (+2.37%)

WFC Wells Fargo
$48.81 /

+1.07 (+2.24%)

HIG Hartford Financial
$67.65 /

+1.05 (+1.58%)

CFG Citizens Financial
$47.55 /

+1.21 (+2.61%)

COIN Coinbase
$263.27 /

-2.11 (-0.80%)

CBOE Cboe Global Markets
$131.07 /

+2.21 (+1.72%)

VOYA Voya Financial
$63.08 /

+0.78 (+1.25%)

AB AllianceBernstein
$52.30 /

+1.455 (+2.86%)

ALLY Ally Financial
$47.04 /

+0.72 (+1.55%)

IBKR Interactive Brokers
$75.55 /

+0.585 (+0.78%)

PNC PNC Financial
$199.91 /

+2.18 (+1.10%)

PWP Perella Weinberg Partners
$12.08 /

+0.24 (+2.03%)

DFS Discover
$111.93 /

+3.28 (+3.02%)

COF Capital One
$145.86 /

+3.96 (+2.79%)

EFX Equifax
$282.12 /

-0.34 (-0.12%)

IVZ Invesco
$22.76 /

+0.325 (+1.45%)

SNV Synovus
$46.95 /

+1.69 (+3.73%)

ZION Zions Bancorp
$63.78 /

+1.81 (+2.92%)

BLK BlackRock
$896.18 /

+0.56 (+0.06%)

SPGI S&P Global
$456.31 /

+0.04 (+0.01%)

ICE IntercontinentalExchange
$130.82 /

+0.65 (+0.50%)

ADS Alliance Data
$72.30 /

+1.545 (+2.18%)

OWL Blue Owl Capital
$15.40 /

+0.33 (+2.19%)

SYF Synchrony
$46.34 /

+1.075 (+2.37%)

11/29/21 Piper Sandler
Synchrony initiated with a Neutral at Piper Sandler
10/29/21 Citi
Citi upgrades Synchrony to Buy on higher loan growth estiamtes
10/29/21 Citi
Synchrony upgraded to Buy from Neutral at Citi
10/20/21
Fly Intel: Top five analyst downgrades
WFC Wells Fargo
$48.81 /

+1.07 (+2.24%)

12/06/21 Morgan Stanley
Wells Fargo upgraded to Overweight from Equal Weight at Morgan Stanley
11/29/21 Odeon Capital
Wells Fargo upgraded to Buy from Hold at Odeon Capital
11/03/21 JPMorgan
Wells Fargo negatively changed language in filing, says JPMorgan
10/15/21 Piper Sandler
Wells Fargo price target raised to $48 from $45 at Piper Sandler
HIG Hartford Financial
$67.65 /

+1.05 (+1.58%)

11/22/21 Goldman Sachs
Hartford Financial initiated with a Buy at Goldman Sachs
11/18/21 Jefferies
Hartford Financial initiated with Hold, $81 target at Jefferies
11/18/21 Jefferies
Hartford Financial initiated with a Hold at Jefferies
11/01/21 RBC Capital
Hartford Financial price target raised to $77 from $68 at RBC Capital
CFG Citizens Financial
$47.55 /

+1.21 (+2.61%)

11/24/21 Morgan Stanley
Citizens Financial resumed with an Overweight at Morgan Stanley
11/22/21 Baird
Citizens Financial weakness a buying opportunity, says Baird
10/11/21 Jefferies
Citizens Financial price target raised to $53 from $47 at Jefferies
08/20/21 Stephens
Investors Bancorp upgraded to Overweight after deal announcement at Stephens
COIN Coinbase
$263.27 /

-2.11 (-0.80%)

11/10/21 Canaccord
Coinbase price target raised to $342 from $325 at Canaccord
11/10/21 JMP Securities
Coinbase price target raised to $405 from $330 at JMP Securities
11/10/21 Piper Sandler
Coinbase price target raised to $440 from $360 at Piper Sandler
10/26/21
Fly Intel: Top five analyst initiations
CBOE Cboe Global Markets
$131.07 /

+2.21 (+1.72%)

10/07/21 Compass Point
Cboe Global Markets upgraded to Buy from Neutral at Compass Point
10/01/21 Piper Sandler
CME shares could see 'meaningful price appreciation,' says Piper Sandler
08/19/21 Citi
Cboe shares likely need more of a takeout premium, says Citi
08/18/21 Raymond James
Cboe could be 'in play' after takeover report denied, says Raymond James
VOYA Voya Financial
$63.08 /

+0.78 (+1.25%)

12/02/21 Goldman Sachs
Voya Financial initiated with a Neutral at Goldman Sachs
11/15/21 Piper Sandler
Voya 2024 EPS growth targets above expectations, says Piper Sandler
06/17/21
Fly Intel: Top five analyst downgrades
06/17/21 Citi
Voya Financial downgraded to Neutral from Buy at Citi
AB AllianceBernstein
$52.30 /

+1.455 (+2.86%)

09/10/21 Citi
AllianceBernstein price target raised to $56 from $54.50 at Citi
08/02/21
Fly Intel: Top five analyst upgrades
08/02/21 Citi
AllianceBernstein upgraded to Buy from Neutral at Citi
07/12/21 Citi
AllianceBernstein price target raised to $44 from $42 at Citi
ALLY Ally Financial
$47.04 /

+0.72 (+1.55%)

12/02/21 Raymond James
Raymond James starts Ally at Outperform, sees benefit of diversification
12/01/21 Raymond James
Ally Financial initiated with an Outperform at Raymond James
11/10/21
Fly Intel: Top five analyst initiations
11/10/21 Citi
Ally Financial resumed with a Buy at Citi
IBKR Interactive Brokers
$75.55 /

+0.585 (+0.78%)

04/21/21 Credit Suisse
Interactive Brokers price target raised to $110 from $92 at Credit Suisse
04/09/21 Jefferies
Charles Schwab price target raised to $76 from $70 at Jefferies
04/05/21 Goldman Sachs
Interactive Brokers price target raised to $83 from $73 at Goldman Sachs
03/05/21 Jefferies
Interactive Brokers initiated with a Buy at Jefferies
PNC PNC Financial
$199.91 /

+2.18 (+1.10%)

12/06/21 Morgan Stanley
PNC Financial cut to Underweight at Morgan Stanley amid big bank rating shake-up
12/06/21 Morgan Stanley
PNC Financial downgraded to Underweight from Equal Weight at Morgan Stanley
10/18/21 Credit Suisse
PNC Financial price target raised to $201 from $195 at Credit Suisse
10/18/21 RBC Capital
PNC Financial price target raised to $220 from $200 at RBC Capital
PWP Perella Weinberg Partners
$12.08 /

+0.24 (+2.03%)

08/20/21 Goldman Sachs
Perella Weinberg Partners initiated with a Buy at Goldman Sachs
07/20/21 Keefe Bruyette
Perella Weinberg Partners initiated with an Outperform at Keefe Bruyette
06/28/21 Wolfe Research
Perella Weinberg Partners transferred with Outperform at Wolfe Research
06/28/21 JMP Securities
Perella Weinberg Partners initiated with an Outperform at JMP Securities
DFS Discover
$111.93 /

+3.28 (+3.02%)

11/02/21
Fly Intel: Top five analyst upgrades
11/02/21 Seaport Global
Discover upgraded to Buy at Seaport Global following post-earnings selloff
11/02/21 Seaport Global
Discover upgraded to Buy from Neutral at Seaport Global
10/29/21 Citi
Citi upgrades Synchrony to Buy on higher loan growth estiamtes
COF Capital One
$145.86 /

+3.96 (+2.79%)

12/01/21
Fly Intel: Top five analyst upgrades
12/01/21 Baird
Capital One upgraded to Neutral after underperformance at Baird
12/01/21 Baird
Capital One upgraded to Neutral from Underperform at Baird
10/27/21 Credit Suisse
Capital One price target raised to $190 from $184 at Credit Suisse
EFX Equifax
$282.12 /

-0.34 (-0.12%)

11/22/21 Exane BNP Paribas
Equifax downgraded to Neutral from Outperform at Exane BNP Paribas
11/12/21 Needham
Equifax price target raised to $335 from $295 at Needham
11/11/21 RBC Capital
Equifax price target raised to $294 from $270 at RBC Capital
10/22/21
Fly Intel: Top five analyst upgrades
IVZ Invesco
$22.76 /

+0.325 (+1.45%)

10/22/21 Evercore ISI
Invesco upgraded to In Line amid Evercore ISI rating 'reshufflng
10/22/21 Evercore ISI
Invesco upgraded to In Line from Underperform at Evercore ISI
09/17/21 Deutsche Bank
State Street, Invesco deal would be 'strategically compelling,' says Deutsche
09/17/21 Citi
Citi doubts State Street will buy Invesco outright, expects share pullback
SNV Synovus
$46.95 /

+1.69 (+3.73%)

10/20/21 RBC Capital
Synovus price target raised to $56 from $51 at RBC Capital
06/07/21 Truist
Synovus price target raised to $57 from $54 at Truist
06/03/21 Piper Sandler
Synovus price target raised to $59 from $54.50 at Piper Sandler
03/24/21 Seaport Global
Synovus initiated with a Buy at Seaport Global
ZION Zions Bancorp
$63.78 /

+1.81 (+2.92%)

11/17/21 Wolfe Research
Huntington downgraded to Peer Perform from Outperform at Wolfe Research
11/17/21 Wolfe Research
Zions Bancorp upgraded to Outperform from Peer Perform at Wolfe Research
10/19/21 DA Davidson
Zions Bancorp price target raised to $66 from $52 at DA Davidson
10/19/21 Raymond James
Zions Bancorp price target raised to $73 from $70 at Raymond James
BLK BlackRock
$896.18 /

+0.56 (+0.06%)

11/03/21
Fly Intel: Top five analyst initiations
11/03/21 BofA
BlackRock reinstated with a Buy at BofA
11/03/21 BofA
BlackRock reinitiated with a Buy at BofA
10/14/21 BMO Capital
BlackRock price target lowered to $794 from $797 at BMO Capital
SPGI S&P Global
$456.31 /

+0.04 (+0.01%)

09/16/21 Oppenheimer
S&P Global price target raised to $550 from $476 at Oppenheimer
07/30/21 Deutsche Bank
S&P Global price target raised to $475 from $450 at Deutsche Bank
07/15/21 Deutsche Bank
S&P Global price target raised to $450 from $435 at Deutsche Bank
07/08/21 Morgan Stanley
S&P Global price target raised to $476 from $460 at Morgan Stanley
ICE IntercontinentalExchange
$130.82 /

+0.65 (+0.50%)

11/02/21 Piper Sandler
IntercontinentalExchange shares not reflecting positives, says Piper Sandler
10/29/21 Deutsche Bank
IntercontinentalExchange price target raised to $152 from $140 at Deutsche Bank
10/26/21 Piper Sandler
IntercontinentalExchange should have rallied 4% yesterday, says Piper Sandler
10/25/21
Fly Intel: Top five analyst initiations
ADS Alliance Data
$72.30 /

+1.545 (+2.18%)

11/01/21 Truist
Alliance Data price target lowered to $115 from $130 at Truist
08/31/21
Fly Intel: Top five analyst upgrades
08/31/21 BofA
Alliance Data upgraded to Buy from Neutral at BofA
08/31/21 BofA
Alliance Data upgraded to Buy from Neutral at BofA
OWL Blue Owl Capital
$15.40 /

+0.33 (+2.19%)

12/06/21 Oppenheimer
Blue Owl Capital initiated with a Perform at Oppenheimer
08/30/21 Keefe Bruyette
Blue Owl Capital initiated with an Outperform at Keefe Bruyette
06/11/21 Goldman Sachs
Blue Owl Capital initiated with a Buy at Goldman Sachs
SYF Synchrony
$46.34 /

+1.075 (+2.37%)

WFC Wells Fargo
$48.81 /

+1.07 (+2.24%)

HIG Hartford Financial
$67.65 /

+1.05 (+1.58%)

CFG Citizens Financial
$47.55 /

+1.21 (+2.61%)

COIN Coinbase
$263.27 /

-2.11 (-0.80%)

CBOE Cboe Global Markets
$131.07 /

+2.21 (+1.72%)

VOYA Voya Financial
$63.08 /

+0.78 (+1.25%)

AB AllianceBernstein
$52.30 /

+1.455 (+2.86%)

ALLY Ally Financial
$47.04 /

+0.72 (+1.55%)

IBKR Interactive Brokers
$75.55 /

+0.585 (+0.78%)

PNC PNC Financial
$199.91 /

+2.18 (+1.10%)

PWP Perella Weinberg Partners
$12.08 /

+0.24 (+2.03%)

DFS Discover
$111.93 /

+3.28 (+3.02%)

COF Capital One
$145.86 /

+3.96 (+2.79%)

EFX Equifax
$282.12 /

-0.34 (-0.12%)

IVZ Invesco
$22.76 /

+0.325 (+1.45%)

SNV Synovus
$46.95 /

+1.69 (+3.73%)

ZION Zions Bancorp
$63.78 /

+1.81 (+2.92%)

BLK BlackRock
$896.18 /

+0.56 (+0.06%)

SPGI S&P Global
$456.31 /

+0.04 (+0.01%)

ICE IntercontinentalExchange
$130.82 /

+0.65 (+0.50%)

ADS Alliance Data
$72.30 /

+1.545 (+2.18%)

OWL Blue Owl Capital
$15.40 /

+0.33 (+2.19%)

  • 08
    Dec
  • 14
    Apr
SYF Synchrony
$46.34 /

+1.075 (+2.37%)

WFC Wells Fargo
$48.81 /

+1.07 (+2.24%)

HIG Hartford Financial
$67.65 /

+1.05 (+1.58%)

CFG Citizens Financial
$47.55 /

+1.21 (+2.61%)

COIN Coinbase
$263.27 /

-2.11 (-0.80%)

CBOE Cboe Global Markets
$131.07 /

+2.21 (+1.72%)

IBKR Interactive Brokers
$75.55 /

+0.585 (+0.78%)

PNC PNC Financial
$199.91 /

+2.18 (+1.10%)

COF Capital One
$145.86 /

+3.96 (+2.79%)

IVZ Invesco
$22.76 /

+0.325 (+1.45%)

BLK BlackRock
$896.18 /

+0.56 (+0.06%)

SPGI S&P Global
$456.31 /

+0.04 (+0.01%)

ICE IntercontinentalExchange
$130.82 /

+0.65 (+0.50%)

OWL Blue Owl Capital
$15.40 /

+0.33 (+2.19%)

SYF Synchrony
$46.34 /

+1.075 (+2.37%)

WFC Wells Fargo
$48.81 /

+1.07 (+2.24%)

HIG Hartford Financial
$67.65 /

+1.05 (+1.58%)

CFG Citizens Financial
$47.55 /

+1.21 (+2.61%)

COIN Coinbase
$263.27 /

-2.11 (-0.80%)

CBOE Cboe Global Markets
$131.07 /

+2.21 (+1.72%)

ALLY Ally Financial
$47.04 /

+0.72 (+1.55%)

IBKR Interactive Brokers
$75.55 /

+0.585 (+0.78%)

PNC PNC Financial
$199.91 /

+2.18 (+1.10%)

DFS Discover
$111.93 /

+3.28 (+3.02%)

COF Capital One
$145.86 /

+3.96 (+2.79%)

EFX Equifax
$282.12 /

-0.34 (-0.12%)

IVZ Invesco
$22.76 /

+0.325 (+1.45%)

ZION Zions Bancorp
$63.78 /

+1.81 (+2.92%)

BLK BlackRock
$896.18 /

+0.56 (+0.06%)

SPGI S&P Global
$456.31 /

+0.04 (+0.01%)

ICE IntercontinentalExchange
$130.82 /

+0.65 (+0.50%)

ADS Alliance Data
$72.30 /

+1.545 (+2.18%)

OWL Blue Owl Capital
$15.40 /

+0.33 (+2.19%)

SYF Synchrony
$46.34 /

+1.075 (+2.37%)

WFC Wells Fargo
$48.81 /

+1.07 (+2.24%)

HIG Hartford Financial
$67.65 /

+1.05 (+1.58%)

COIN Coinbase
$263.27 /

-2.11 (-0.80%)

CBOE Cboe Global Markets
$131.07 /

+2.21 (+1.72%)

PWP Perella Weinberg Partners
$12.08 /

+0.24 (+2.03%)

DFS Discover
$111.93 /

+3.28 (+3.02%)

COF Capital One
$145.86 /

+3.96 (+2.79%)

EFX Equifax
$282.12 /

-0.34 (-0.12%)

IVZ Invesco
$22.76 /

+0.325 (+1.45%)

ZION Zions Bancorp
$63.78 /

+1.81 (+2.92%)

ICE IntercontinentalExchange
$130.82 /

+0.65 (+0.50%)

ADS Alliance Data
$72.30 /

+1.545 (+2.18%)

OWL Blue Owl Capital
$15.40 /

+0.33 (+2.19%)

Conference/Events
Economic Club of New York to host a virtual event » 09:24
12/07/21
12/07
09:24
12/07/21
09:24
MS

Morgan Stanley

$99.21 /

+1.105 (+1.13%)

Carla Harris, Vice…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
MS Morgan Stanley
$99.21 /

+1.105 (+1.13%)

MS Morgan Stanley
$99.21 /

+1.105 (+1.13%)

12/03/21
Fly Intel: Top five analyst upgrades
12/03/21 Citi
Morgan Stanley upgraded to Buy from Neutral at Citi
10/18/21 Citi
Morgan Stanley price target raised to $105 from $100 at Citi
10/15/21
Fly Intel: Top five analyst downgrades
MS Morgan Stanley
$99.21 /

+1.105 (+1.13%)

MS Morgan Stanley
$99.21 /

+1.105 (+1.13%)

MS Morgan Stanley
$99.21 /

+1.105 (+1.13%)

MS Morgan Stanley
$99.21 /

+1.105 (+1.13%)

Periodicals
Apple success in China aided by CEO Cook's $275B deal, The Information says » 09:17
12/07/21
12/07
09:17
12/07/21
09:17
AAPL

Apple

$165.35 /

+3.5 (+2.16%)

Apple's…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
AAPL Apple
$165.35 /

+3.5 (+2.16%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

07:31 Today Credit Suisse
Broadcom price target raised to $620 from $580 at Credit Suisse
06:33 Today Morgan Stanley
Apple price target raised to $200 from $164 at Morgan Stanley
12/06/21
Fly Intel: Top five analyst initiations
12/06/21 JPMorgan
Apple iPhone 13 demand remains 'healthy and robust,' says JPMorgan
AAPL Apple
$165.35 /

+3.5 (+2.16%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

Hot Stocks
Jamf announces its platform has helped deploy one million Macs » 08:41
12/07/21
12/07
08:41
12/07/21
08:41
JAMF

Jamf Holding

$30.11 /

+0.09 (+0.30%)

, AAPL

Apple

$165.35 /

+3.5 (+2.16%)

Jamf (JAMF) announced its…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
JAMF Jamf Holding
$30.11 /

+0.09 (+0.30%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

JAMF Jamf Holding
$30.11 /

+0.09 (+0.30%)

11/18/21 Piper Sandler
Jamf competitive threat from Apple is minimal, says Piper Sandler
11/12/21 Piper Sandler
Jamf selloff on Apple product a buying opportunity, says Piper Sandler
11/12/21 Barclays
Jamf Holding shares to remain range-bound, says Barclays
11/10/21 Needham
Needham sees Apple Business Essentials functionality competitive with Jamf Now
AAPL Apple
$165.35 /

+3.5 (+2.16%)

07:31 Today Credit Suisse
Broadcom price target raised to $620 from $580 at Credit Suisse
06:33 Today Morgan Stanley
Apple price target raised to $200 from $164 at Morgan Stanley
12/06/21
Fly Intel: Top five analyst initiations
12/06/21 JPMorgan
Apple iPhone 13 demand remains 'healthy and robust,' says JPMorgan
JAMF Jamf Holding
$30.11 /

+0.09 (+0.30%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

  • 10
    Jun
AAPL Apple
$165.35 /

+3.5 (+2.16%)

JAMF Jamf Holding
$30.11 /

+0.09 (+0.30%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

Hot Stocks
Instagram introduces new tools for teen safety » 08:24
12/07/21
12/07
08:24
12/07/21
08:24
FB

Facebook; also tag MVRS

$317.92 /

+10.9 (+3.55%)

, MVRS

Meta

/

+

In a blog post, Instagram…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return in 9 minutes

Get Free Trial

ShowHide Related Items >><<
FB Facebook; also tag MVRS
$317.92 /

+10.9 (+3.55%)

MVRS Meta
/

+

FB Facebook; also tag MVRS
$317.92 /

+10.9 (+3.55%)

12/06/21 HSBC
HSBC upgrades Meta to Hold after 19% selloff from peak
12/06/21 HSBC
Meta upgraded to Hold from Reduce at HSBC
12/02/21 UBS
Meta assumed with a Buy at UBS
11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
MVRS Meta
/

+

12/06/21 HSBC
HSBC upgrades Meta to Hold after 19% selloff from peak
12/06/21 HSBC
Meta upgraded to Hold from Reduce at HSBC
12/02/21 UBS
Meta assumed with a Buy at UBS
11/19/21 JMP Securities
DoubleVerify may see $200M opportunity from Facebook news, says JMP Securities
FB Facebook; also tag MVRS
$317.92 /

+10.9 (+3.55%)

FB Facebook; also tag MVRS
$317.92 /

+10.9 (+3.55%)

MVRS Meta
/

+

FB Facebook; also tag MVRS
$317.92 /

+10.9 (+3.55%)

MVRS Meta
/

+

FB Facebook; also tag MVRS
$317.92 /

+10.9 (+3.55%)

Hot Stocks
Pharvaris announces changes to board of directors » 08:20
12/07/21
12/07
08:20
12/07/21
08:20
PHVS

Pharvaris

$15.45 /

+0.64 (+4.32%)

, AZN

AstraZeneca

$55.40 /

+1.155 (+2.13%)

Pharvaris (PHVS)…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
PHVS Pharvaris
$15.45 /

+0.64 (+4.32%)

AZN AstraZeneca
$55.40 /

+1.155 (+2.13%)

PHVS Pharvaris
$15.45 /

+0.64 (+4.32%)

03/02/21 SVB Leerink
Pharvaris initiated with an Outperform at SVB Leerink
03/02/21 Oppenheimer
Pharvaris initiated with an Outperform at Oppenheimer
03/02/21 Morgan Stanley
Pharvaris initiated with an Overweight at Morgan Stanley
03/02/21 SVB Leerink
Pharvaris initiated with an Outperform at SVB Leerink
AZN AstraZeneca
$55.40 /

+1.155 (+2.13%)

04:41 Today Jefferies
AstraZeneca downgraded to Hold from Buy at Jefferies
12/03/21 Cantor Fitzgerald
Corvus Pharmaceuticals price target raised to $8 from $5 at Cantor Fitzgerald
11/29/21 Morgan Stanley
AstraZeneca price target raised to 10,200 GBp from 10,000 GBp at Morgan Stanley
11/22/21 Bryan Garnier
AstraZeneca downgraded to Buy from Conviction Buy at Bryan Garnier
PHVS Pharvaris
$15.45 /

+0.64 (+4.32%)

AZN AstraZeneca
$55.40 /

+1.155 (+2.13%)

  • 05
    Feb
AZN AstraZeneca
$55.40 /

+1.155 (+2.13%)

AZN AstraZeneca
$55.40 /

+1.155 (+2.13%)

AZN AstraZeneca
$55.40 /

+1.155 (+2.13%)

Recommendations
Broadcom price target raised to $620 from $580 at Credit Suisse » 07:31
12/07/21
12/07
07:31
12/07/21
07:31
AVGO

Broadcom

$564.69 /

+6.295 (+1.13%)

, AAPL

Apple

$165.35 /

+3.5 (+2.16%)

Credit Suisse analyst…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
AVGO Broadcom
$564.69 /

+6.295 (+1.13%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AVGO Broadcom
$564.69 /

+6.295 (+1.13%)

12/06/21 JPMorgan
Broadcom price target raised to $655 from $600 at JPMorgan
12/06/21 UBS
Broadcom price target raised to $660 from $580 at UBS
12/03/21 Oppenheimer
Broadcom price target raised to $650 from $575 at Oppenheimer
11/15/21 Argus
Broadcom price target raised to $620 from $560 at Argus
AAPL Apple
$165.35 /

+3.5 (+2.16%)

06:33 Today Morgan Stanley
Apple price target raised to $200 from $164 at Morgan Stanley
12/06/21
Fly Intel: Top five analyst initiations
12/06/21 JPMorgan
Apple iPhone 13 demand remains 'healthy and robust,' says JPMorgan
12/06/21 KeyBanc
Apple initiated with an Overweight at KeyBanc
AVGO Broadcom
$564.69 /

+6.295 (+1.13%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AVGO Broadcom
$564.69 /

+6.295 (+1.13%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AVGO Broadcom
$564.69 /

+6.295 (+1.13%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AVGO Broadcom
$564.69 /

+6.295 (+1.13%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

AAPL Apple
$165.35 /

+3.5 (+2.16%)

Periodicals
Disney to appoint Geoff Morrell as chief communications officer, Variety says » 06:44
12/07/21
12/07
06:44
12/07/21
06:44
DIS

Disney

$150.36 /

+4.1 (+2.80%)

, BP

BP

$27.33 /

+0.42 (+1.56%)

Disney (DIS) will appoint…

Story temporarily locked.
To read stories as they happen please subscribe, Login above, or return tomorrow

Get Free Trial

ShowHide Related Items >><<
DIS Disney
$150.36 /

+4.1 (+2.80%)

BP BP
$27.33 /

+0.42 (+1.56%)

DIS Disney
$150.36 /

+4.1 (+2.80%)

11/29/21 Loop Capital
Disney price target lowered to $190 from $205 at Loop Capital
11/22/21 Wells Fargo
Disney price target lowered to $196 from $203 at Wells Fargo
11/16/21 Citi
Disney price target lowered to $210 from $230 at Citi
11/15/21 Roth Capital
DraftKings price target lowered to $34 from $39 at Roth Capital
BP BP
$27.33 /

+0.42 (+1.56%)

12/03/21 Deutsche Bank
BP upgraded to Buy on 'strong' fundamental's at Deutsche Bank
12/03/21 Deutsche Bank
BP upgraded to Buy from Hold at Deutsche Bank
11/29/21 JPMorgan
BP price target raised to 570 GBp from 530 GBp at JPMorgan
11/09/21 Morgan Stanley
BP price target raised to 401 GBp from 388 GBp at Morgan Stanley
DIS Disney
$150.36 /

+4.1 (+2.80%)

BP BP
$27.33 /

+0.42 (+1.56%)

DIS Disney
$150.36 /

+4.1 (+2.80%)

BP BP
$27.33 /

+0.42 (+1.56%)

DIS Disney
$150.36 /

+4.1 (+2.80%)

BP BP
$27.33 /

+0.42 (+1.56%)

DIS Disney
$150.36 /

+4.1 (+2.80%)

BP BP
$27.33 /

+0.42 (+1.56%)

Hot Stocks
Janssen announces additional efficacy, safety data from CYPRESS study » 06:37
12/07/21
12/07
06:37
12/07/21
06:37
JNJ

Johnson & Johnson

$162.91 /

+3.555 (+2.23%)

Janssen of Johnson &…

Janssen of Johnson & Johnson announced additional vaccine efficacy and safety data from its Phase 2b CYPRESS study of its respiratory syncytial virus, or RSV, adult vaccine candidate. Results show that the vaccine candidate was highly effective in protecting against three clinical definitions of lower respiratory tract disease, or LRTD, caused by RSV, demonstrating vaccine efficacy of 70% to 80% in adults aged 65 and older. These data were presented at the Eighth European Scientific Working Group on Influenza, or ESWI, meeting, held virtually, December 4-7. Following an initial proof-of-concept study with Janssen's RSV adult vaccine candidate in a human challenge study, Janssen combined Ad26.RSV.preF with a prefusion F, or preF, protein for induction of a more optimal immune response. This combination single-dose regimen was evaluated in the Phase 2b CYPRESS study, which enrolled 5,782 participants across 40 sites in the United States. Participants were randomized to receive Ad26.RSV.preF or placebo and were followed through a single RSV season. The CYPRESS study primary endpoint was the first occurrence of LRTD caused by RSV, during the first RSV season following vaccination, according to any of three case definitions: 3 symptoms of lower respiratory tract infection; 2 symptoms of LRTI; or 2 symptoms of LRTI or 1 symptom of LRTI with 1 systemic symptom. Vaccine efficacy for LRTD case definitions 1, 2, and 3 were 80%, 75%, and 70%, respectively. Efficacy was 70% for the first occurrence of any symptomatic RSV-associated acute respiratory infection. Similarly, RSV-specific patient-reported outcomes data from the CYPRESS trial found less severe RSV symptoms in participants with RSV-associated ARI in the vaccine group than in the placebo group. Vaccinated participants who experienced RSV-associated ARI had milder symptoms and a faster return to usual health than the participants in the placebo group. Solicited adverse events and unsolicited AEs were assessed from time of vaccination to Day 8 and Day 29, respectively, in a safety subset of 695 participants. Serious AEs, or SAEs, were collected in all participants until the end of the RSV season or six months post-vaccination, whichever occurred later. In the vaccine group, the most frequent solicited systemic AEs were fatigue, myalgia and headache, and the most frequent solicited local AE was pain/tenderness. These events were typically mild to moderate in severity and short in duration, resolving within days after vaccination. The rates of unsolicited AEs were similar in both groups; in the overall study population, the rate of SAEs was similar between groups, and none were found to be related to the vaccine. Based on positive results from the Phase 2b CYPRESS study, which is the first large study evaluating the efficacy and safety of Janssen's RSV vaccine candidate against RSV-associated LRTD in vaccinated adults aged 65 and older in the United States, Janssen initiated the global Phase 3 EVERGREEN study. The Phase 3 study will evaluate the efficacy, safety and immunogenicity of Janssen's adult vaccine candidate against LRTD caused by RSV, when compared with placebo in approximately 23,000 adults aged 60 years and older throughout North America and a selection of countries across Europe, Asia and the Southern Hemisphere.

ShowHide Related Items >><<
JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

11/29/21 Credit Suisse
Credit Suisse stays Outperform on J&J as intra-quarter checks find pharma upside
11/09/21 Mizuho
Alkermes price target lowered to $33 from $36 at Mizuho
11/08/21 Morgan Stanley
Morgan Stanley bullish on 2seventy Bio, initiates with an Overweight
10/20/21 Raymond James
Johnson & Johnson price target lowered to $178 from $183 at Raymond James
JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

JNJ Johnson & Johnson
$162.91 /

+3.555 (+2.23%)

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.